Company No: 13315046 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2025		2024
		£		£
				Restated
Current assets		20,602		54,145
Prepayments and accrued income		2,644		4,870
Creditors: amounts falling due within one year		( 314,656)		( 58,806)
Net current (liabilities)/assets		( 291,410)		209
Total assets less current liabilities		( 291,410)		209
Creditors: amounts falling due after more than one year		-		( 155,735)
Accruals and deferred income		( 1,397)		( 2,490)
Net liabilities		( 292,807)		( 158,016)
Capital and reserves		( 292,807)		( 158,016)

For the financial year ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of CDotBio Limited (registered number: 13315046) were approved and authorised for issue by the Board of Directors on 09 December 2025 and were signed on its behalf by:

T Garcia Millan Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 13315046). The address of its registered office is Future Space North Gate, Filton Road, Bristol, BS34 8RB, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	6		4

3. Prior year adjustment

In the prior year, a £50,000 loan to the company was incorrectly classed as turnover. A prior year adjustment has been made to correct this.

The impact of the prior year adjustment on the Profit and Loss account figures reported for the year ended 30 April 2024 is as follows:
-Turnover reduced by £50,000 from £181,591 to £131,591.
-Deficit for the year increased by £50,000 from £132,287 to £182,287.

The impact of the prior year adjustment on the balance sheet at 30 April 2024 is:
-Creditors: Amounts falling due within one year increased by £50,000 from £105,735 to £155,735.
-Net liabilities increased by £50,000 from £108,016 to £158,016.

4. Events after the balance sheet date

On 18 September 2025, a further 1,296,879 ordinary shares of £0.001 each were allotted. Of these, 812,167 shares were issued at par value, and 484,712 shares were issued at a value of £0.4376 per share. As part of the share allotment, loans to the company of £260,565 at 30 April 2025 were converted into share capital.